Shat­tuck Labs ends si­lence with a shout-out on $118M raise for fu­sion pro­tein work

Af­ter four years of rel­a­tive ob­scu­ri­ty in a res­i­den­tial Austin neigh­bor­hood, Shat­tuck Labs has emerged with $118 mil­lion from Red­mile Group and over 10 oth­er in­vestors.

Co-found­ed in 2016 by CEO Tay­lor Schreiber, an im­mu­nol­o­gist and a lym­phoma sur­vivor, the start­up an­nounced an im­muno-on­col­o­gy part­ner­ship with Take­da the next year, but kept an oth­er­wise low pro­file. SEC records in­di­cate they raised a $46 mil­lion Se­ries A in 2018, but they nev­er put out a press re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER